Thomas Lanot

Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detection

Patrick Séraissol, Thomas Lanot, Sarah Baklouti et al. · Journal of Pharmaceutical and Biomedical Analysis · 2022 · 29 citations

Quantification Methods, Drug Analysis, Antimicrobial Susceptibility +15

Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods

David Metsu, Thomas Lanot, François Fraissinet et al. · Clinica Chimica Acta · 2017 · 17 citations

Hemodialysis, Renal Function, Unbound Fraction +12

Comparing ultrafiltration and equilibrium dialysis to measure unbound plasma dolutegravir concentrations based on a design of experiment approach

David Metsu, Thomas Lanot, François Fraissinet et al. · Scientific Reports · 2020 · 16 citations · Full text

Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19

Stéphanie Ruiz, Didier Concordet, Thomas Lanot et al. · International Journal of Antimicrobial Agents · 2020 · 12 citations · Full text

Critical Care Medicine, Hydroxychloroquine Lung Pharmacokinetics, Respiratory Infection +4

Efficacy of dihydroartemisinin/piperaquine in patients with non-complicated <i>Plasmodium falciparum</i> malaria in Yaoundé, Cameroon

Mélissa Mairet-Khedim, Sandrine E. Nsango, Christelle Maffo Ngou et al. · Journal of Antimicrobial Chemotherapy · 2021 · 10 citations · Full text